Genzyme Corporation is pursuing lawsuits against Lupin Ltd. and
Lupin Pharmaceuticals and Impax Laboratories, Inc., alleging
infringement of Renagel and Renvela patents.
Beginning in January 2009, the company received notices from…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.